Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.04.16.718870

Towards patient-specific biomechanical human brain models

Abstract

Reliable characterization of spatial variations in brain tissue stiffness is essential for predictive biomechanical modeling, yet most current methods rely on coarse regional parameter assignments based on invasive mechanical testing. In this study, we propose a new approach to obtain subject-specific mechanical properties at voxel resolution from in vivo diffusion tensor magnetic resonance imaging (DTI) based on a linear regression between the fractional anisotropy (FA) from DTI and experimentally measured stiffness values. To assess how such heterogeneity in mechanical properties influences simulated brain deformation, we construct a finite element model based on two material parameterizations of the same human brain: one employing nine anatomically defined regions, each with uniform material parameters, and another in which the shear modulus is assigned voxel-wise on the corresponding FA value. Applying this FA-stiffness mapping yields a smoothly varying mechanical property distribution that better captures local microstructural differences not represented by region-wise parameterizations. Both parameterizations are subjected to an identical atrophy-driven loading scenario. They exhibit comparable overall volume loss, but diverge in regional behavior. The voxel-resolved parameterization predicts more pronounced ventricular expansion and differs in the displacement and stretch distributions, indicating that variability in stiffness can alter local predicted responses even when global outcomes appear similar. This work presents a pipeline for estimating individualized mechanical properties directly from imaging protocols that are routinely performed on patients, with important implications for brain biomechanics. While the approach depends on a simplified linear FA-stiffness relation and assumes isotropic constitutive behavior, it provides a framework for integrating imaging-based microstructure into subject-specific simulations. Future validation against in vivo or experimental deformation data is needed to determine the fidelity and clinical utility of FA-derived stiffness fields.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tueni, N., Rauh, B., Hinrichsen, J., Rampp, S., Doerfler, A., Budday, S.. 2026-04-17. Towards patient-specific biomechanical human brain models. https://doi.org/10.64898/2026.04.16.718870

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗